Catalyst Funds Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,712
Closed -$30K 570
2025
Q1
$30K Buy
+13,712
New +$30K 0.01% 431